This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Jul 10;28(20):3210-2.

doi: 10.1200/JCO.2010.28.9322. Epub 2010 May 24.

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?

David J Kerr, Rachel Midgley

PMID: 20498404
DOI: 10.1200/JCO.2010.28.9322

Editorial

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?

David J Kerr et al. J Clin Oncol. 2010.

. 2010 Jul 10;28(20):3210-2.

doi: 10.1200/JCO.2010.28.9322. Epub 2010 May 24.

Authors

David J Kerr, Rachel Midgley

PMID: 20498404
DOI: 10.1200/JCO.2010.28.9322

No abstract available

PubMed Disclaimer

Comment in

Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch?
Ng K, Schrag D. Ng K, et al. J Clin Oncol. 2010 Jul 10;28(20):3207-10. doi: 10.1200/JCO.2010.28.9314. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498398 No abstract available.

Comment on

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri V, Ribic C, Grothey A, Moore M, Zaniboni A, Seitz JF, Sinicrope F, Gallinger S. Sargent DJ, et al. J Clin Oncol. 2010 Jul 10;28(20):3219-26. doi: 10.1200/JCO.2009.27.1825. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498393 Free PMC article.

Similar articles

Adjuvant 5-FU based chemotherapy for colon cancer: match or miss the mismatch?
D'Incalci M. D'Incalci M. Eur J Cancer. 2009 Feb;45(3):316-7. doi: 10.1016/j.ejca.2008.10.040. Epub 2008 Dec 25. Eur J Cancer. 2009. PMID: 19097881 No abstract available.
Predictive value of defective mismatch repair in adjuvant colon cancer.
Atkins CD. Atkins CD. J Clin Oncol. 2010 Dec 10;28(35):e746; author reply e747. doi: 10.1200/JCO.2010.31.8824. Epub 2010 Nov 1. J Clin Oncol. 2010. PMID: 21041713 No abstract available.
Optimal duration of fluorouracil plus levamisole colon cancer surgical adjuvant therapy.
O'Connell MJ, Kahn MJ, Erlichman C, Goldberg RM, Shepherd LE. O'Connell MJ, et al. J Clin Oncol. 1996 Oct;14(10):2887. J Clin Oncol. 1996. PMID: 8874353 No abstract available.
[Adjuvant treatment for colon carcinoma. Results and perspectives].
Wein A, Riedel C, Lehnert T, Wakker R, Reingruber B, Teichmann W, Kohnen R, Herfarth C, Hohenberger W, Hahn EG. Wein A, et al. Dtsch Med Wochenschr. 1998 May 22;123(21):674-80. doi: 10.1055/s-2007-1024037. Dtsch Med Wochenschr. 1998. PMID: 9638096 Review. German. No abstract available.
[Adjuvant therapy for colon cancer].
Lordick F, Rosenberg R, Stein HJ, Peschel C, Siewert JR. Lordick F, et al. Dtsch Med Wochenschr. 2004 Oct 29;129(44):2366-71. doi: 10.1055/s-2004-835270. Dtsch Med Wochenschr. 2004. PMID: 15497107 Review. German. No abstract available.

See all similar articles

Cited by

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.
Kelly P, Paulin F, Lamont D, Baker L, Clearly S, Exon D, Thompson A. Kelly P, et al. Br J Cancer. 2012 Feb 28;106(5):955-61. doi: 10.1038/bjc.2012.15. Epub 2012 Jan 31. Br J Cancer. 2012. PMID: 22294182 Free PMC article.
Radiotherapy response in microsatellite instability related rectal cancer.
Shin JS, Tut TG, Yang T, Lee CS. Shin JS, et al. Korean J Pathol. 2013 Feb;47(1):1-8. doi: 10.4132/KoreanJPathol.2013.47.1.1. Epub 2013 Feb 25. Korean J Pathol. 2013. PMID: 23482947 Free PMC article.
Prognostic markers for colorectal cancer: estimating ploidy and stroma.
Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ. Danielsen HE, et al. Ann Oncol. 2018 Mar 1;29(3):616-623. doi: 10.1093/annonc/mdx794. Ann Oncol. 2018. PMID: 29293881 Free PMC article.
Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers.
Liu X, Zhang H, Lai L, Wang X, Loera S, Xue L, He H, Zhang K, Hu S, Huang Y, Nelson RA, Zhou B, Zhou L, Chu P, Zhang S, Zheng S, Yen Y. Liu X, et al. Clin Sci (Lond). 2013 May;124(9):567-78. doi: 10.1042/CS20120240. Clin Sci (Lond). 2013. PMID: 23113760 Free PMC article.
Prognostic markers for colorectal cancer.
Tyrrell HEJ, Kerr D. Tyrrell HEJ, et al. Oncotarget. 2018 Sep 4;9(69):33060-33061. doi: 10.18632/oncotarget.26012. eCollection 2018 Sep 4. Oncotarget. 2018. PMID: 30237850 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.